Q2 2024 LifeMD Inc Earnings Call Transcript
Key Points
- LifeMD Inc (LFMD) reported a 67% year-over-year revenue growth in its core telehealth business, surpassing expectations.
- The company achieved positive adjusted EBITDA one quarter earlier than guidance, driven by strong telehealth performance.
- LifeMD Inc (LFMD) generated positive net cash flow for the third consecutive quarter, reflecting the strength of its telehealth operations.
- The company successfully expanded its weight management offerings, with revenue up 82% sequentially and a significant increase in patient sign-ups.
- LifeMD Inc (LFMD) is integrating AI technology to improve efficiency, achieving a 200% improvement in response times for patient inquiries.
- The WorkSimpli business faced challenges due to a tougher advertising environment and executional missteps, impacting overall performance.
- Consolidated adjusted EBITDA guidance was revised downward due to the first half softness in the WorkSimpli subsidiary.
- The number of WorkSimpli active subscribers contracted by 8%, indicating a decline in this segment.
- LifeMD Inc (LFMD) reported a GAAP net loss attributable to common stockholders of $7.7 million for the second quarter.
- The company is still in the process of divesting WorkSimpli, with no definitive timeline provided for the completion of this goal.
Good afternoon. Thank you for joining us today to discuss LifeMD's results for the second quarter ended June 30, 2024. Joining the call today are Justin Schreiber, Chairman and Chief Executive Officer; and Marc Benathen, Chief Financial Officer. Following management's prepared remarks, we will open the call for question-and-answer session.
Before we begin, I'd like to remind everyone that during this call, the company will make a number of forward-looking statements, which are subject to numerous risks and uncertainties that may cause actual results to differ materially from those projected. These risks and uncertainties are described in the company's 10-K and 10-Q filings and within other filings that LifeMD may make with the SEC from time to time.
Forward-looking statements made during this call are based on current information available to the company as of today, August 7, 2024. The company assumes no obligation to update or revise any forward-looking statements after today's call except as required by law.
Also, please note that management will be discussing certain non
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
